Recombinant PDGFRA (Tovetumab Biosimilar) antibody

Catalog No. ABIN7675858

The Human Monoclonal anti-PDGFRA (Tovetumab Biosimilar) antibody is suitable to detect PDGFRA (Tovetumab Biosimilar) in samples from Human. It has been validated for ELISA, BLI, FACS, Func and SPR.

Quick Overview for Recombinant PDGFRA (Tovetumab Biosimilar) antibody (ABIN7675858)

Target: PDGFRA (Tovetumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PDGFRA (Tovetumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-PDGFRA (Tovetumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-PDGFRA / CD140a Reference Antibody (tovetumab)

Characteristics: Anti-PDGFRA / CD140a Reference Antibody (tovetumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 IgG4 S228P, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for PDGFRA (Tovetumab Biosimilar)

Target: PDGFRA (Tovetumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P16234